Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 6,941 | 9,041 | 14,018 | 0 | 0 |
| Gross Profit | 6,941 | 9,041 | 14,018 | N/A | N/A |
| Operating Expenses | 231,054 | 314,841 | 123,548 | 36,901 | 25,204 |
| Operating Income | -224,113 | -305,800 | -109,530 | -36,901 | -25,204 |
| Interest Expense | 0 | 0 | 0 | 0 | 10 |
| Other Income | 11,719 | 12,837 | 2,724 | 5 | 503 |
| Pre-tax Income | -212,394 | -292,963 | -106,806 | -36,896 | -24,711 |
| Net Income Continuous | -212,394 | -292,963 | -106,806 | -36,896 | -24,711 |
| Net Income | $-212,394 | $-292,963 | $-106,806 | $-36,896 | $-24,711 |
| EPS Basic Total Ops | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 |
| EPS Basic Continuous Ops | -2.43 | -5.00 | -5.38 | -3.04 | -2.14 |
| EPS Diluted Total Ops | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 |
| EPS Diluted Continuous Ops | -2.43 | -5.00 | -5.38 | -3.04 | -2.14 |
| EPS Diluted Before Non-Recurring Items | -2.43 | -2.40 | -1.31 | -3.09 | -2.14 |
| EBITDA(a) | $-223,997 | $-306,597 | $-109,314 | $-36,270 | $-24,449 |